ofatumumab
0 sources
ofatumumab
Summary
ofatumumab is a type of chemical entity[1]. ofatumumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (77 views/month).[2]
Key Facts
- ofatumumab's instance of is recorded as type of chemical entity[3].
- ofatumumab's CAS Registry Number is recorded as 679818-59-8[4].
- ofatumumab's ATC code is recorded as L01XC10[5].
- ofatumumab's subclass of is recorded as chemical compound[6].
- ofatumumab's has use is recorded as medication[7].
- ofatumumab's Commons category is recorded as Ofatumumab[8].
- ofatumumab's MeSH descriptor ID is recorded as C527517[9].
- ofatumumab's has part is recorded as carbon[10].
- ofatumumab's ChEMBL ID is recorded as CHEMBL1201836[11].
- ofatumumab's Guide to Pharmacology Ligand ID is recorded as 6778[12].
- ofatumumab's Freebase ID is recorded as /m/02ppkkv[13].
- ofatumumab's UNII is recorded as M95KG522R0[14].
- ofatumumab's DrugBank ID is recorded as DB06650[15].
- ofatumumab's NCI Thesaurus ID is recorded as C66952[16].
- ofatumumab's HSDB ID is recorded as 8170[17].
- ofatumumab's NDF-RT ID is recorded as N0000180305[18].
- ofatumumab's medical condition treated is recorded as B-cell lymphoma[19].
- ofatumumab's medical condition treated is recorded as non-Hodgkin lymphoma[20].
- ofatumumab's medical condition treated is recorded as diffuse large B-cell lymphoma[21].
- ofatumumab's medical condition treated is recorded as chronic lymphocytic leukemia[22].
- ofatumumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'ofatumumab'}[23].
- ofatumumab's subject has role is recorded as antineoplastic[24].
- ofatumumab's subject has role is recorded as monoclonal antibody[25].
- ofatumumab's UMLS CUI is recorded as C1832027[26].
- ofatumumab's RxNorm CUI is recorded as 712566[27].
Why It Matters
ofatumumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (77 views/month).[2] ofatumumab has Wikipedia articles in 15 language editions, a strong signal of global cultural recognition.[28] ofatumumab is known by 9 alternative names across languages and contexts.[29]